Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease in Endocrinology Clinics.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zobair M,Younossi

第一单位： Inova Medicine, Inova Health System, Falls Church, Virginia; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia; Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia. Electronic address: Zobair.Younossi@inova.org.

作者： Zobair M,Younossi ^[1] ; Linda,Henry ^[2] ; Scott,Isaacs ^[3] ; Kenneth,Cusi ^[4]

作者单位： Inova Medicine, Inova Health System, Falls Church, Virginia; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia; Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia. Electronic address: Zobair.Younossi@inova.org. ^[1] Inova Medicine, Inova Health System, Falls Church, Virginia; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia. ^[2] Emory University School of Medicine, Atlanta, Georgia. ^[3] Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida. ^[4]

关键词 FIB-4 NAFLD T2D noninvasive tests obesity

主题词人类(Humans);糖尿病, 2型(Diabetes Mellitus, Type 2);肝(Liver);肝硬化(Liver Cirrhosis);肝肿瘤(Liver Neoplasms)

DOI 10.1016/j.eprac.2023.06.012

PMID 37406857

发布时间 2023-11-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交